Sailong Pharmaceutical Group Co.,Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 155.6 million compared to CNY 129.58 million a year ago. Revenue was CNY 156.78 million compared to CNY 131.36 million a year ago.

Net income was CNY 2.99 million compared to CNY 1.05 million a year ago. Basic earnings per share from continuing operations was CNY 0.017 compared to CNY 0.006 a year ago. Diluted earnings per share from continuing operations was CNY 0.017 compared to CNY 0.006 a year ago.